Flatiron Assist™

Your go-to solution for evidence-based care

With Flatiron Assist™, physicians can quickly select evidence-based treatment options, while collecting data that can support reimbursement submissions and contribute to research projects—all at the point of care, without disrupting or adding to daily workflows.

Request a demo

Decision support designed by clinicians, for clinicians

Thanks to Flatiron Assist’s intuitive design, clinicians can make evidence-based treatment decisions quickly and safely with no need to use a decision tree.

Smart tooling and insights ease your administrative burden

Flatiron Assist™ captures key data points to speed up prior authorizations and surfaces insights to help practices achieve success in value-based arrangements.

The nice thing about Flatiron Assist is that you can get right where you want to go—and get there quickly—without having to dig through an algorithm.

Sylvia Richey, MD
Associate Medical Director, West Cancer Center

Product highlights

  • Trusted clinical content
    Built according to NCCN Guidelines®, Flatiron Assist™ ties to Flatiron’s NCCN® Regimens and supports NCCN® Categories of Preference out of the box for all users.
  • Practice and payer preferences
    Customize pathways on top of the NCCN Guidelines® according to practice- or payer-specific preferences.
  • Seamless workflow
    Oncologists can quickly find the right treatment for their patient and collect clinical data needed to measure concordance, without ever having to leave OncoEMR®.
  • OncoEMR® reporting
    Measure concordance, pathways compliance, and variation in care patterns through the OncoEMR® reporting suite.

Flatiron Assist™: driving value with every treatment decision

Learn how Hematology Oncology Associates of Central New York reduced administrative burden and observed treatment patterns by implementing Flatiron Assist™, the oncology-specific, clinical decision support tool.

Read case study

Improvements within six-month observation period
100%
relative use of preferred regimens for small-cell lung cancer
96%
relative use of preferred regimens for esophageal cancer
94%
relative use of preferred regimens for pancreatic cancer

Let us tell you more.

We will email you to start the conversation.

Thank you. We'll be in touch shortly.

The patient photos and clinical data appearing on this page are for illustrative purposes only; they are not derived from real patient data.

Journal of Clinical Pathways

Supporting optimal, value-based and sustainable cancer care delivery

As the cancer care landscape continues to evolve, oncologists must stay up to date on the latest treatment options for their patients while also navigating the administrative complexities of running a successful oncology practice.

OncLive

AI makes inroads into oncology practices

Oncology practices large and small are starting to tap into the power of data analytics and artificial intelligence (AI) to help identify patients at risk of relapse or adverse effects (AEs) and to assist in making clinical decisions on care.

Press Release

Flatiron Health announces clinical decision support application through Epic’s App Orchard

Available now in the App Orchard, Flatiron Assist™ is a SMART® on FHIR® application that will launch from the patient’s chart in Epic, eliminating the need for duplicate data entry outside the electronic medical record.